Investigating immune cells in sarcoidosis patients
Studie Av Cellulära Uttryck I Lymfkörtlar, Lungsköljvätska Och Blod Vid Sarkoidos.
This study is trying to learn more about immune cells in people with sarcoidosis to understand why some patients have ongoing symptoms while others get better on their own.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 560 (estimated) |
| Ages | 18 Years to 90 Years |
| Sex | All |
| Sponsor | Region Stockholm Government |
| Locations | 1 site (Stockholm) |
| Trial ID | NCT05751447 on ClinicalTrials.gov |
What this trial studies
This study focuses on understanding the role of immune cells in patients with sarcoidosis, an inflammatory disease that primarily affects the lungs and lymph nodes. It aims to explore the mechanisms behind why some patients experience chronic disease while others resolve spontaneously. The study involves interventions such as lymph node puncture and bronchoscopy to collect samples for analysis. By examining the immune response and genetic factors, researchers hope to gain insights into disease progression and potential treatment strategies.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals suspected of having sarcoidosis who are Swedish-speaking and can comprehend the study protocol.
Not a fit: Patients who do not have a suspicion of sarcoidosis or are unable to participate due to language or comprehension barriers may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and management of sarcoidosis, potentially enhancing patient outcomes.
How similar studies have performed: While there is ongoing research into sarcoidosis, this specific approach focusing on immune cell mechanisms is relatively novel and may provide new insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Suspicion of sarcoidosis * Swedish speaking * Able to understand and approve of study protocol * No contraindications for planned interventions Exclusion Criteria: * No suspicion of sarcoidosis * Not Swedish-speking * Not able to understand study protocol * Not approving of stydy protocol * Contraindications for planned interventions
Where this trial is running
Stockholm
- Karolinska University Hospital — Stockholm, Sweden (Recruiting)
Study contacts
- Study coordinator: Susanna Kullberg, MD
- Email: susanna.kullberg@ki.se
- Phone: 070-2715639
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.